Intrathecal baclofen for the treatment of intractable spasticity of spine or brain etiology

Neuromodulation

Volumn 3, Issue 2, 2000, Pages 75-81

  Avellino, Anthony M ^a   Loeser, John D ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Baclofen; Cerebral palsy; Multiple sclerosis; Programmable intrathecal pump; Spasticity; Spinal cord injury; Traumatic brain injury

Indexed keywords

BACLOFEN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HALLUCINATION; HUMAN; INFUSION PUMP; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; RESPIRATION DEPRESSION; SEIZURE; SOMNOLENCE; SPASTICITY; SPINAL CORD INJURY;

EID: 0034084061     PISSN: 10947159     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1403.2000.00075.x     Document Type: Article

References (26)

1. Abel NA, Smith RA. Intrathecal baclofen for treatment of intractable spinal spasticity. Arch Phys Med Rehabil 1994;75:54-58.
2. Albright AL, Barry MJ, Painter MJ, Shultz B. Infusion of intrathecal baclofen for generalized dystonia in cerebral palsy. J Neurosurg 1998;88:73-76.
3. Becker R, Alberti O, Bauer BL. Continuous intrathecal baclofen infusion in severe spasticity after traumatic or hypoxic brain injury. J Neurol 1997;244:160-166.
4. Coffey RJ, Cahill D, Steers W, et al. Intrathecal baclofen for intractable spasticity of spinal origin: Results of a long-term multicenter study. J Neurosurg 1993;78:226-232.
5. Meythaler JM, McCary A, Hadley MN. Prospective assessment of continuous intrathecal infusion of baclofen for spasticity caused by acquired brain injury: A preliminary report. J Neurosurg 1997;87:415-419.
6. Ochs G, Struppler A, Meyerson BA, et al. Intrathecal baclofen for long-term treatment of spasticity: A multicentre study. J Neurol Neurosurg Psychiatry 1989;52:933-939.
7. Ordia JI, Fischer E, Adamski E, Spatz EL. Chronic intrathecal delivery of baclofen by a programmable pump for the treatment of severe spasticity. J Neurosurg 1996;85:452-457.
8. Penn RD. Intrathecal baclofen for spasticity of spinal origin: Seven years of experience. J Neurosurg 1992;77:236-240.
9. Stayer C, Tronnier V, Dressnandt J, et al. Intrathecal baclofen therapy for stiff-man syndrome and progressive encephalomyelopathy with rigidity and myoclonus. Neurology 1997;49:1591-1597.
10. Albright AL. Intrathecal baclofen in cerebral palsy movement disorders. J Child Neurol 1996;11:S29-S35.
11. Armstrong RW, Steinbok P, Cochrane DD, Kube SD, Fife SE, Farrell K. Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin. J Neurosurg 1997;87:409-414.
12. Loubser PG, Narayan RK, Sandin KJ, Donovan WH, Russell KD. Continuous infusion of intrathecal baclofen: Long-term effects on spasticity in spinal cord injury. Paraplegia 1991;29:48-64.
13. Meythaler JM, Steers WD, Tuel SM, Cross LL, Haworth CS. Continuous intrathecal baclofen in spinal cord spasticity. Am J Phys Med Rehabil 1992;71:321-327.
14. Penn RD, Savoy SM, Corcos D, et al. Intrathecal baclofen for severe spinal spasticity. N Engl J Med 1989;320:1517-1521.
15. Saltuari L, Kronenberg M, Marosi MJ, et al. Long-term intrathecal baclofen treatment in supraspinal spasticity. Acta Neurol (Napoli) 1992;14:195-207.
16. Akman MN, Loubser PG, Donovan WH, O'Neill ME, Rossi CD. Intrathecal baclofen: Does tolerance occur? Paraplegia 1993;31:516-520.
17. Kroin JS, Penn RD. Cerebrospinal fluid pharmacokinetics of lumbar intrathecal baclofen. In: Lakke JPWF, Delhaas EM, Rutgers AWF, eds. Parenteral Drug Therapy in Spasticity and Parkinson's Disease - New Trends in Clinical Neurology Series. Park Ridge NJ: Parthenon, 1992:67-77.
18. Middel B, Kuipers-Upmeijer H, Bouma J, et al. Effect of intrathecal baclofen delivered by an implanted programmable pump on health related quality of life in patients with severe spasticity. J Neurol Neurosurg Psychiatry 1997;63:204-209.
19. Nance P, Schryvers O, Schmidt B, Dubo H, Loveridge B, Fewer D. Intrathecal baclofen therapy for adults with spinal spasticity: Therapeutic efficacy and effect on hospital admissions. Can J Neurol Sci 1995;22:22-29.
20. Albright AL, Barron WB, Fasick MP, Polinko P, Janosky J. Continuous intrathecal baclofen infusion for spasticity of cerebral origin. JAMA 1993;270:2475-2477.
21. Albright AL, Cervi A, Singletary J. Intrathecal baclofen for spasticity in cerebral palsy. JAMA 1991;265:1418-1422.
22. Seitz RJ, Blank B, Kiwit JCW, Benecke R. Stiff-person syndrome with anti-glutamic acid decarboxylase autoantibodies: Complete remission of symptoms after intrathecal baclofen administration. J Neurol 1995;242:618-622.
23. Mertens P, Parise M, Garcia-Larrea L, Benneton C, Millet MF, Sindou M. Long-term clinical, electrophysiological and urodynamic effects of chronic intrathecal baclofen infusion for treatment of spinal spasticity. Acta Neurochir 1995;64:17-25.
24. Penn RD, York MM, Paice JA. Catheter systems for intrathecal drug delivery. J Neurosurg 1995;83:215-217.
25. Albright AL. Baclofen in the treatment of cerebral palsy. J Child Neurol 1996;11:77-83.
26. Muller-Schwefe G, Penn RD. Physostigmine in the treatment of intrathecal baclofen overdose - Report of three cases. J Neurosurg 1989;71:273-275.